for GI rates see side effects
She's pretty much lying here and saying she had three shots only
Randomized trials have shown that liraglutide and semaglutide can improve walking distance in people with PAD, while observational studies have linked semaglutide and tirzepatide to lower risks of amputation, lower-extremity revascularization, and mortality
Compare realistic out-of-pocket options in our GLP-1 cost guide
6.7 Appetite, Energy Intake and Energy Expenditure To seek explanations for the body weight loss observed with liraglutide treatment, the effects of liraglutide on appetite sensations, energy intake and energy expenditure have been assessed in subjects with type 2 diabetes [62, 65]
Together, they reduce avoidable GLP-1 utilization and lower per-unit drug costs, preserving access without sacrificing affordability